High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care. (Special issue on diabetes and COVID-19: the IDF perspective.)

We aim to describe the prevalence of diabetic ketoacidosis (DKA) in individuals admitted to a single centre with COVID-19 We identified 218 individuals hospitalised with COVID-19, of these four fulfilled criteria for DKA (4/218, 1 8%) We conclude DKA is common and severe in individuals hospitalised with COVID-19